Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, BANERJEE, KOYELI. The prosecution is currently limited to 1 distinct art unit, reflecting a focused review of the company's pharmaceutical innovations. This concentration within a single art unit can lead to a more specialized examination of the biotechnology claims.
The busiest examiner, BANERJEE, KOYELI, manages 1 pending office action. Since the total number of pending actions is 1, this examiner is the only official currently reviewing the company's pending biotechnology applications. This singular focus allows for a direct interpretation of the examiner's requirements for the portfolio. The busiest examiner pending figure of 1 confirms that the company's current prosecution strategy is entirely centered on the feedback from this specific individual.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BANERJEE, KOYELI | 1 | 33.3% | +0.0% |
| Art Unit | Apps |
|---|---|
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17925816 | COMPOSITION COMPRISING PEPSTATIN AND ALGINIC ACID OR A SALT THEREOF, AND USE THEREOF | BANERJEE, KOYELI | 1658 | §103 | Final Rejection | — | Pending | Nov 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialDrugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Koyeli Banerjee has the most, with 1 of Drugs Minerals And Generics Italia S R L In Forma Abbreviata D M G Italia S R L's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
